
Delee
Delee is a YC Winter 2017 (W17) company. Based in Monterrey, N.L., Mexico. Team of 18.
About Delee
Summary
Delee builds a blood-based diagnostic device that detects and monitors cancer by isolating and analyzing circulating tumor cells. The device targets early-stage cancer diagnosis and ongoing treatment tracking, replacing or supplementing more invasive tissue biopsies and conventional lab workflows. Oncologists and diagnostic labs are the primary users.
From the Y Combinator listing
Blood testing device for early diagnosis of cancer and treatment…
Delee is a medical device company that developed a blood-testing device for early diagnosis of cancer and treatment monitoring through the isolation and analysis of the circulating tumor cells.
Facts
- Healthcare / Healthcare -> Diagnostics
- Monterrey, N.L., Mexico
- 18
- Active
- Early
Founders (3)
- Alejandro Abarca-Blanco
- Juan Felipe Yee De León
Score every batch against your own thesis
GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.
How Accelerator intelligence works